Cancer Pain Assessment and Classification

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Apr 13

PMID 30974857

Citations 81

Authors

Augusto Caraceni

Morena Shkodra

Affiliations

Soon will be listed here.

Abstract

More than half of patients affected by cancer experience pain of moderate-to-severe intensity, often in multiple sites, and of different etiologies and underlying mechanisms. The heterogeneity of pain mechanisms is expressed with the fluctuating nature of cancer pain intensity and clinical characteristics. Traditional ways of classifying pain in the cancer population include distinguishing pain etiology, clinical characteristics related to pain and the patient, pathophysiology, and the use of already validated classification systems. Concepts like breakthrough, nociceptive, neuropathic, and mixed pain are very important in the assessment of pain in this population of patients. When dealing with patients affected by cancer pain it is also very important to be familiar to the characteristics of specific pain syndromes that are usually encountered. In this article we review methods presently applied for classifying cancer pain highlighting the importance of an accurate clinical evaluation in providing adequate analgesia to patients.

Citing Articles

Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology.

Antonuzzo A, Gonella S, Blasi L, Carnio S, Franzese C, Marano L Healthcare (Basel). 2025; 13(3).

PMID: 39942401 PMC: 11816693. DOI: 10.3390/healthcare13030212.

ZC3H15 suppression ameliorates bone cancer pain through inhibiting neuronal oxidative stress and microglial inflammation.

Huang L, Yan T, Wang B, Li H, Zhou N Neoplasia. 2025; 61:101123.

PMID: 39908779 PMC: 11847137. DOI: 10.1016/j.neo.2025.101123.

Effect of deep diaphragmatic breathing on pain in patients with metastatic gastrointestinal cancers.

Rezaei M, Salari N, Aznab M, Jasmi S, Abdi A, Shohaimi S Heliyon. 2024; 10(22):e40283.

PMID: 39624272 PMC: 11609224. DOI: 10.1016/j.heliyon.2024.e40283.

Repetitive Transcranial Magnetic Stimulation: Is it an Effective Treatment for Cancer Pain?.

Du Y, Li Y, Hu J, Fang R, Liu Y, Cai L Pain Ther. 2024; 14(1):47-66.

PMID: 39551863 PMC: 11751341. DOI: 10.1007/s40122-024-00679-2.

Coping with cancer pain: a qualitative study to explore pain perception and self-coping strategies of patients with cancer in Sri Lanka.

Edirisinghe N, Makuloluwa P, Amarasekara T, Goonewardena C BMJ Open. 2024; 14(11):e085510.

PMID: 39542485 PMC: 11575247. DOI: 10.1136/bmjopen-2024-085510.

References

Caraceni A, Portenoy R . An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999; 82(3):263-274. DOI: 10.1016/S0304-3959(99)00073-1. View

Swanwick M, Haworth M, Lennard R . The prevalence of episodic pain in cancer: a survey of hospice patients on admission. Palliat Med. 2001; 15(1):9-18. DOI: 10.1191/026921601668030190. View

Bennett M . The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001; 92(1-2):147-57. DOI: 10.1016/s0304-3959(00)00482-6. View

Caraceni A, Weinstein S . Classification of cancer pain syndromes. Oncology (Williston Park). 2002; 15(12):1627-40, 1642; discussion 1642-3, 1646-7. View

Turk D, Monarch E, Williams A . Cancer patients in pain: considerations for assessing the whole person. Hematol Oncol Clin North Am. 2002; 16(3):511-25. DOI: 10.1016/s0889-8588(02)00015-1. View

Hwang S, Chang V, Fairclough D, Kasimis B . Development of a cancer pain prognostic scale. J Pain Symptom Manage. 2002; 24(4):366-78. DOI: 10.1016/s0885-3924(02)00488-8. View

Hwang S, Chang V, Kasimis B . Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain. 2003; 101(1-2):55-64. DOI: 10.1016/s0304-3959(02)00293-2. View

Zeppetella G, Ribeiro M . Pharmacotherapy of cancer-related episodic pain. Expert Opin Pharmacother. 2003; 4(4):493-502. DOI: 10.1517/14656566.4.4.493. View

Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J . Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114(1-2):29-36. DOI: 10.1016/j.pain.2004.12.010. View

10.

Fainsinger R, Nekolaichuk C, Lawlor P, Neumann C, Hanson J, Vigano A . A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage. 2005; 29(3):224-37. DOI: 10.1016/j.jpainsymman.2004.05.008. View

11.

Bankhead C, Kehoe S, Austoker J . Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005; 112(7):857-65. DOI: 10.1111/j.1471-0528.2005.00572.x. View

12.

Portenoy R, Hagen N . Breakthrough pain: definition, prevalence and characteristics. Pain. 1990; 41(3):273-281. DOI: 10.1016/0304-3959(90)90004-W. View

13.

Freynhagen R, Baron R, Gockel U, Tolle T . painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006; 22(10):1911-20. DOI: 10.1185/030079906X132488. View

14.

Bennett M, Attal N, Backonja M, Baron R, Bouhassira D, Freynhagen R . Using screening tools to identify neuropathic pain. Pain. 2006; 127(3):199-203. DOI: 10.1016/j.pain.2006.10.034. View

15.

Niscola P, Cartoni C, Romani C, Brunetti G, DElia G, Cupelli L . Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol. 2007; 86(9):671-6. DOI: 10.1007/s00277-007-0296-4. View

16.

Jones K, Vojir C, Hutt E, Fink R . Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev. 2007; 44(2):305-14. DOI: 10.1682/jrrd.2006.05.0051. View

17.

Spiro S, Gould M, Colice G . Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl):149S-160S. DOI: 10.1378/chest.07-1358. View

18.

Treede R, Jensen T, Campbell J, Cruccu G, Dostrovsky J, Griffin J . Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2007; 70(18):1630-5. DOI: 10.1212/01.wnl.0000282763.29778.59. View

19.

Fainsinger R, Nekolaichuk C . A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer. 2008; 16(6):547-55. DOI: 10.1007/s00520-008-0423-3. View

20.

Knudsen A, Aass N, Fainsinger R, Caraceni A, Klepstad P, Jordhoy M . Classification of pain in cancer patients--a systematic literature review. Palliat Med. 2009; 23(4):295-308. DOI: 10.1177/0269216309103125. View